Skip to main content
. 2023 Feb 28;14:1119315. doi: 10.3389/fimmu.2023.1119315

Table 3.

The results of quantitative analysis for the association between included variants and the risk of PD in different models.

Gene Variant Sample size# Allele OR [95%CI]
Ref/Alt Allele model Dominant model Recessive model
Genes of cytokines
TNF-α rs1800629 6/1485/1464 G/A 1.12 [0.96, 1.30] 1.11 [0.94, 1.31] 1.33 [0.83, 2.13]
rs1799964 3/735/653 T/C 1.24 [0.85, 1.79] 1.10 [0.70,1.72] 3.19 [1.66,6.13]***
IL-1α rs1800587 9/2129/2000 C/T 1.03[0.91,1.16] 1.01 [0.88, 1.16] 1.17 [0.84, 1.64]
IL-1β rs16944 8/1857/1622 C/T 1.05 [0.85, 1.31] 1.06 [0.84, 1.33] 1.16 [0.77, 1.74]
IL-6 rs1800795 4/924/1093 G/C 0.82 [0.63, 1.06] 0.66 [0.55, 0.79]**** 0.85 [0.55, 1.30]
IL-10 rs1800896 6/1557/1540 A/G 1.00 [0.90, 1.11] 1.04 [0.88, 1.23] 0.94 [0.78, 1.14]
rs1800871 4/1472/1288 C/A 1.10 [0.98, 1.24] 1.07 [0.89, 1.29] 1.18 [0.98, 1.42]
Genes involved in the oxidative stress
NOS1 rs2682826 5/1246/1606 C/T 1.11 [0.89,1.38] 1.11 [0.86,1.45] 1.23 [0.92,1.66]
rs1060826 3/949/764 G/A 1.07 [0.86,1.34] 1.14 [0.94,1.40] 1.02 [0.53, 1.96]
MnSOD rs4880 3/409/253 T/C 1.14 [0.86, 1.53] 1.08 [0.71, 1.64] 1.52 [0.82, 2.82]
NFE2L2 rs6706649 4/2048/1869 G/A 1.02 [0.88, 1.19] 0.99 [0.84, 1.17] 1.44 [0.82, 2.52]
rs6721961 4/2076/1873 C/A 1.02[0.91,1.14] 1.01 [0.88,1.16] 1.04 [0.79,1.35]
rs35652124 4/2076/1868 A/G 1.03 [0.93, 1.13] 0.99 [0.81,1.21] 1.10 [0.92,1.31]
rs2706110 3/2399/2191 G/A 1.06 [0.87, 1.30] 1.08 [0.83, 1.41] 0.99 [0.76, 1.30]
rs10183914 3/2405/2210 G/A 0.95 [0.87, 1.04] 0.95 [0.85, 1.07] 0.91 [0.76, 1.08]
rs1806649 3/2412/2199 G/A 0.92 [0.77, 1.11] 0.94 [0.83, 1.07] 0.90 [0.56, 1.46]
rs2001350 3/2141/2207 A/G 1.06[0.92,1.23] 1.09[0.83,1.43] 1.27[0.67,2.42]
Genes of neurotoxin-associated enzymes
CYP2D6 rs3892097 14/1727/2087 G/A 1.14 [1.00, 1.29]* 1.29 [1.02, 1.63]* 1.06 [0.78, 1.44]
A2637 5/485/598 A/- 1.12 [0.58, 2.16] 1.12 [0.58, 2.18] NA
PON1 rs705379 3/908/1158 C/T 0.96 [0.85,1.08] 0.97 [0.80,1.18] 0.92 [0.75,1.12]
rs854560 11/2781/3176 T/A 1.20 [1.10, 1.30]*** 1.21 [1.08, 1.35]*** 1.37 [1.15, 1.62]***
rs662 10/2205/2538 A/G 1.01 [0.92, 1.10] 0.99 [0.88,1.12] 1.05 [0.88,1.24]
CYP2E1 rs2031920 3/454/501 C/T 1.13 [0.89, 1.44] 1.14 [0.86, 1.52] 1.31 [0.62, 2.76]
NAT2 rs1799929 3/406/573 C/T 0.96 [0.80, 1.16] 1.03 [0.79, 1.36] 0.84 [0.59, 1.18]
rs1799930 3/405/573 G/A 1.02 [0.80, 1.30] 1.02 [0.75, 1.37] 1.06 [0.61, 1.83]
MDR1/
ABCB1
rs1128503 4/918/918 C/T 0.98 [0.86, 1.12] 1.11 [0.91, 1.36] 0.84 [0.59, 1.19]
rs1045642 10/2159/2753 C/T 1.06 [0.97, 1.15] 1.04 [0.91, 1.19] 1.12 [0.98, 1.28]
rs2032582 7/1499/2091 T/G(A) 0.96 [0.87, 1.06] 0.99 [0.83, 1.17] 0.93 [0.80, 1.07]
Genes of metabolism-associated enzymes
HFE rs1800562 9/1644/4654 G/A 0.89 [0.73, 1.08] 0.88[0.72, 1.08] 0.93 [0.35, 2.51]
rs1799945 8/1217/4151 C/G 1.03 [0.89, 1.19] 1.02 [0.87, 1.21] 1.18 [0.70, 1.99]
MTHFR rs1801133 13/2250/2565 C/T 1.11 [0.93, 1.34] 1.15 [0.90, 1.47] 1.02 [0.85, 1.23]
rs1801131 4/550/527 A/C 1.05 [0.75, 1.47] 0.97 [0.76, 1.23] 0.77 [0.51, 1.14]
Inflammatory polymorphic locus identified by genome-wide association studies (GWAS) study
BST1 rs11724635 3/1293/1441 C/A 1.07 [0.96, 1.20] 1.08 [0.92, 1.27] 1.12 [0.92, 1.37]
rs11931532 3/1868/3782 T/C 0.90 [0.82, 0.99]* 0.91 [0.78, 1.06] 0.82 [0.70, 0.96]*
HLA-DRB1 rs660895 3/3041/4318 A/G 0.80 [0.74, 0.87]**** 0.79 [0.71, 0.87]**** 0.67 [0.52, 0.86]**
CCDC62 rs12817488 3/1608/1649 A/G 0.80 [0.73, 0.89]*** 0.77 [0.66, 0.89]*** 0.74 [0.62, 0.87]***

# Number of articles/patients/controls included for quantitative analysis. The Allele (Ref/Alt) represents refer allele and alter allele, respectively. OR[95%CI] represents the odd ratios with 95% confidence interval. The values of OR [95%CI] in bold indicate statistically significant. The */**/***/**** represents the significant variants with p< 0.05, p<0.01, p<0.001, p<0.00001, respectively.